What the source record establishes
Agilent presents OpenLab CDS as a chromatography data system for instrument control, data acquisition, analysis, reporting, administration, and laboratory data operations.
The maintained taxonomy connects that documented market position to Guided Laboratory Procedure And Worksheet Execution. This page keeps the claim at the level supported by the source: Agilent OpenLab CDS presents an offering relevant to this work. It does not silently convert a product description into an observed result, a conformity finding, or a universal recommendation.
Current fit signal: Analytical laboratories controlling chromatography instruments and managing acquisition, processing, review, reporting, and data records across laboratory networks.
What guided laboratory procedure and worksheet execution means in this market
Guided Laboratory Procedure And Worksheet Execution should be evaluated as an operating chain rather than a feature label. The chain begins with a named business condition and governed input, passes through configured logic and accountable review, produces an output or action, handles exceptions, and preserves enough evidence for another person to reconstruct the decision later.
Method, procedure, and laboratory execution control
The maintained relationship among approved methods, parameters, specifications, versioned instructions, execution steps, observations, calculations, deviations, and reviewer evidence.
Boundary: Electronic execution does not establish method validity, analyst competence, procedural adherence, or a scientifically correct result.
Activities that may sit inside the review
- method and procedure version
- step and parameter control
- operator guidance and observations
- calculation and acceptance logic
- deviation and review evidence
Who owns the decision
A capability can be technically available while operating ownership remains fragmented. The evaluation should name the person accountable for policy or business interpretation, the person responsible for configuration and data, the reviewer with authority to resolve exceptions, the approver of release or action, and the owner of monitoring and retirement.
Related domain records commonly place responsibility with laboratory science, quality control, method owners, lab execution and validation teams. The local operating model may assign those roles differently, but it should not leave them implicit.
Agilent OpenLab CDS should be asked to distinguish what the product decides, what it recommends, what it merely displays, and what remains an organizational judgment. A generic “human in the loop” statement is inadequate unless the human has time, context, evidence, and authority.
Evidence package to request from Agilent OpenLab CDS
- The exact product and package proposed, with a dated list of native, integrated, partner, service, and customer-owned components.
- A representative input set, its authoritative source, permitted use, quality checks, and version history.
- The configured workflow from intake through review, exception, approval, action, retention, and export.
- A normal result and at least two difficult exceptions, including one caused by missing or contradictory evidence.
- Role and access definitions for configuration, review, approval, override, monitoring, and administration.
- An implementation map naming integrations, migrations, customer work, provider work, services, test environments, and release gates.
- A retained decision record showing source, logic or model version, user action, timestamps, disposition, and downstream effect.
- A measurement plan with baseline, observation period, population, error threshold, exclusions, and stop condition.
Demonstration script
- Which exact Agilent OpenLab CDS product, edition, module, service, and geography support guided laboratory procedure and worksheet execution?
- What source data, content, rules, and integrations does Agilent OpenLab CDS require before the workflow can begin?
- Where does human judgment enter, and which person can approve, reject, override, or stop the guided laboratory procedure and worksheet execution workflow?
- How does the proposed configuration handle missing data, conflicting evidence, changed rules, and an expired or revoked approval?
- What record preserves inputs, transformations, user actions, exceptions, outputs, timestamps, and downstream consequences?
- Which parts are native, partner-delivered, service-delivered, or left to the customer?
- What can be exported at implementation, audit, renewal, migration, and exit?
- Which observation would falsify the current fit hypothesis for Agilent OpenLab CDS?
- Which version applies to this sample and test?
- What is guided enforced observed or manually entered?
- How are conditional steps repeats and deviations represented?
- Which calculations and limits are versioned?
Use the same scenario with every finalist. Let the provider explain differences in architecture, but keep the business condition, required evidence, exception, and expected decision record constant. That makes the evaluation comparable without pretending that unlike products should receive one synthetic score.
Failure modes and boundary conditions
- scientific method development
- manufacturing batch execution outside laboratory work
- assumed conformance from digital guidance
No independent test established instrument coverage, calculation correctness, configured controls, validation, data integrity, scale, or outcomes.
A buyer should also distinguish absence of public evidence from evidence of absence. If Agilent OpenLab CDS has not publicly documented a required detail, the correct status is “not established in this review” until a current, attributable source or direct observation resolves it.
Authority and standards context
21 CFR 211.194
It anchors a buyer's record model for sample identity, method control, raw data, calculation, result review, and traceable exceptions in relevant drug-manufacturing laboratories.
Interpretation boundary: The section does not prescribe a LIMS, ELN, CDS, SDMS, or LES architecture and does not establish that a configured system satisfies its requirements.
This mapping identifies a workflow that may help organize evidence. It does not state that Agilent OpenLab CDS conforms to, complies with, or is certified against the authority.
FDA Computer Software Assurance Guidance
It gives laboratory and quality buyers a disciplined way to separate vendor evidence, configured intended use, process risk, assurance activity, unscripted testing, and retained objective evidence.
Interpretation boundary: The guidance does not eliminate validation obligations, guarantee an outcome, or determine the right assurance activity for a specific configured use.
This mapping identifies a workflow that may help organize evidence. It does not state that Agilent OpenLab CDS conforms to, complies with, or is certified against the authority.
EU GMP Chapter 4
Laboratory architecture should show which system owns each instruction, specification, raw record, result, review, approval, exception, and retained copy across electronic and paper processes.
Interpretation boundary: A repository or electronic signature feature does not establish compliant documentation practice or the suitability of a record design.
This mapping identifies a workflow that may help organize evidence. It does not state that Agilent OpenLab CDS conforms to, complies with, or is certified against the authority.
Comparable records to inspect
The following organizations also have current official positioning mapped to guided laboratory procedure and worksheet execution. Inclusion is a research pathway, not a shortlist or claim of equivalence.
- Shimadzu LabSolutions — Chromatography And Analytical Data System with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
- Thermo Fisher Scientific Chromeleon — Chromatography And Analytical Data System with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
- Waters Empower — Chromatography And Analytical Data System with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
- Agilent SLIMS — Enterprise LIMS And Laboratory-Informatics Suite with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
- Apprentice — Regulated Laboratory Execution And Manufacturing-Quality Platform with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
- Autoscribe Informatics — Configurable Specialist And Midmarket LIMS with documented positioning relevant to Guided Laboratory Procedure And Worksheet Execution
Official authority sources
The following primary authority pages support the standards context used in this record. They define an evaluation boundary; they do not endorse Agilent OpenLab CDS or establish product conformity.
21 CFR 211.194
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
FDA Computer Software Assurance Guidance
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
EU GMP Chapter 4
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
Conditional conclusion
Agilent OpenLab CDS belongs in deeper evaluation for guided laboratory procedure and worksheet execution when its documented chromatography and analytical data system operating model matches the buyer's real workflow, the proposed package contains the required components, and a representative test produces reviewable evidence through normal and exception paths. The conclusion should be reversed or narrowed when the product boundary, source data, authority mapping, integration burden, human decision rights, exportability, or measured result does not meet the stated approval conditions.